Severe gastrointestinal issues: Individuals with a history of severe gastrointestinal problems, such as gastroparesis or pancreatitis, should steer clear of this medication, as semaglutide can exacerbate these conditions
Why is this so cool
Tirzepatide pushed this further, achieving up to 22 percent weight loss in the SURMOUNT-1 trial
He told Glossy that the FDA recently told him that no safety data has been submitted for BPC-157, which is the first step toward approval
Evaluating causal protective effect of dual GLP-1R/GIPR agonists on MASLD: a Mendelian randomization and colocalization study
GLP-1 medicationsincluding household names like Ozempic, Wegovy, Byetta, and Victozamimic a natural hormone your gut produces after eating, called GLP-1 (short for glucagon-like peptide-1)